BETH ISRAEL DEACONESS MEDICAL CENTER
I4C 2.0: Immunotherapy for Cure
I4C 2.0: Immunotherapy for Cure is a funding opportunity from BETH ISRAEL DEACONESS MEDICAL CENTER, up to 4653643, closing July 31, 2026.
Jul 31, 2026
(0d left)Overview
SUMMARY The goals of I4C 2.0 are to advance our scientific understanding of the viral reservoir and to develop immunologic strategies for HIV-1 remission and eradication by a highly collaborative and multifaceted research program involving partnerships among academia, industry, government, and the community. Our…